Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts

Maria Laura Falchetti, Maria Patrizia Mongiardi, Paolo Fiorenzo, Giovanna Petrucci, Francesco Pierconti, Igea D'Agnano, Giorgio D'Alessandris, Giulio Alessandri, Maurizio Gelati, Lucia Ricci-Vitiani, Giulio Maira, Luigi Maria Larocca, Andrea Levi, Roberto Pallini

Research output: Contribution to journalArticle

Abstract

Tumor angiogenesis is a complex process that involves a series of interactions between tumor cells and endothelial cells (ECs). In vitro, glioblastoma multiforme (GBM) cells are known to induce an increase in proliferation, migration and tube formation by the ECs. We have previously shown that in human GBM specimens the proliferating ECs of the tumor vasculature express the catalytic component of telomerase, hTERT, and that telomerase can be upregulated in human ECs by exposing these cells to GBM in vitro. Here, we developed a controlled in vivo assay of tumor angiogenesis in which primary human umbilical vascular endothelial cells (HUVECs) were subcutaneously grafted with or without human GBM cells in immunocompromised mice as Matrigel implants. We found that primary HUVECs did not survive in Matrigel implants, and that telomerase upregulation had little effect on HUVEC survival. In the presence of GBM cells, however, the grafted HUVECs not only survived in Matrigel implants but developed tubule structures that integrated with murine microvessels. Telomerase upregulation in HUVECs enhanced such effect. More importantly, inhibition of telomerase in HUVECs completely abolished tubule formation and greatly reduced survival of these cells in the tumor xenografts. Our data demonstrate that telomerase upregulation by the ECs is a key requisite for GBM tumor angiogenesis.

Original languageEnglish
Pages (from-to)1236-1242
Number of pages7
JournalInternational Journal of Cancer
Volume122
Issue number6
DOIs
Publication statusPublished - Mar 15 2008

Fingerprint

Telomerase
Glioblastoma
Heterografts
Endothelial Cells
Umbilicus
Neoplasms
Up-Regulation
Cell Survival
Microvessels

Keywords

  • Glioblastoma multiforme
  • HUVEC
  • Telomerase
  • Tumor xenograft

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Falchetti, M. L., Mongiardi, M. P., Fiorenzo, P., Petrucci, G., Pierconti, F., D'Agnano, I., ... Pallini, R. (2008). Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. International Journal of Cancer, 122(6), 1236-1242. https://doi.org/10.1002/ijc.23193

Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. / Falchetti, Maria Laura; Mongiardi, Maria Patrizia; Fiorenzo, Paolo; Petrucci, Giovanna; Pierconti, Francesco; D'Agnano, Igea; D'Alessandris, Giorgio; Alessandri, Giulio; Gelati, Maurizio; Ricci-Vitiani, Lucia; Maira, Giulio; Larocca, Luigi Maria; Levi, Andrea; Pallini, Roberto.

In: International Journal of Cancer, Vol. 122, No. 6, 15.03.2008, p. 1236-1242.

Research output: Contribution to journalArticle

Falchetti, ML, Mongiardi, MP, Fiorenzo, P, Petrucci, G, Pierconti, F, D'Agnano, I, D'Alessandris, G, Alessandri, G, Gelati, M, Ricci-Vitiani, L, Maira, G, Larocca, LM, Levi, A & Pallini, R 2008, 'Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts', International Journal of Cancer, vol. 122, no. 6, pp. 1236-1242. https://doi.org/10.1002/ijc.23193
Falchetti ML, Mongiardi MP, Fiorenzo P, Petrucci G, Pierconti F, D'Agnano I et al. Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. International Journal of Cancer. 2008 Mar 15;122(6):1236-1242. https://doi.org/10.1002/ijc.23193
Falchetti, Maria Laura ; Mongiardi, Maria Patrizia ; Fiorenzo, Paolo ; Petrucci, Giovanna ; Pierconti, Francesco ; D'Agnano, Igea ; D'Alessandris, Giorgio ; Alessandri, Giulio ; Gelati, Maurizio ; Ricci-Vitiani, Lucia ; Maira, Giulio ; Larocca, Luigi Maria ; Levi, Andrea ; Pallini, Roberto. / Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. In: International Journal of Cancer. 2008 ; Vol. 122, No. 6. pp. 1236-1242.
@article{03654dab5bfe4e46917d89748bf3517a,
title = "Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts",
abstract = "Tumor angiogenesis is a complex process that involves a series of interactions between tumor cells and endothelial cells (ECs). In vitro, glioblastoma multiforme (GBM) cells are known to induce an increase in proliferation, migration and tube formation by the ECs. We have previously shown that in human GBM specimens the proliferating ECs of the tumor vasculature express the catalytic component of telomerase, hTERT, and that telomerase can be upregulated in human ECs by exposing these cells to GBM in vitro. Here, we developed a controlled in vivo assay of tumor angiogenesis in which primary human umbilical vascular endothelial cells (HUVECs) were subcutaneously grafted with or without human GBM cells in immunocompromised mice as Matrigel implants. We found that primary HUVECs did not survive in Matrigel implants, and that telomerase upregulation had little effect on HUVEC survival. In the presence of GBM cells, however, the grafted HUVECs not only survived in Matrigel implants but developed tubule structures that integrated with murine microvessels. Telomerase upregulation in HUVECs enhanced such effect. More importantly, inhibition of telomerase in HUVECs completely abolished tubule formation and greatly reduced survival of these cells in the tumor xenografts. Our data demonstrate that telomerase upregulation by the ECs is a key requisite for GBM tumor angiogenesis.",
keywords = "Glioblastoma multiforme, HUVEC, Telomerase, Tumor xenograft",
author = "Falchetti, {Maria Laura} and Mongiardi, {Maria Patrizia} and Paolo Fiorenzo and Giovanna Petrucci and Francesco Pierconti and Igea D'Agnano and Giorgio D'Alessandris and Giulio Alessandri and Maurizio Gelati and Lucia Ricci-Vitiani and Giulio Maira and Larocca, {Luigi Maria} and Andrea Levi and Roberto Pallini",
year = "2008",
month = "3",
day = "15",
doi = "10.1002/ijc.23193",
language = "English",
volume = "122",
pages = "1236--1242",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts

AU - Falchetti, Maria Laura

AU - Mongiardi, Maria Patrizia

AU - Fiorenzo, Paolo

AU - Petrucci, Giovanna

AU - Pierconti, Francesco

AU - D'Agnano, Igea

AU - D'Alessandris, Giorgio

AU - Alessandri, Giulio

AU - Gelati, Maurizio

AU - Ricci-Vitiani, Lucia

AU - Maira, Giulio

AU - Larocca, Luigi Maria

AU - Levi, Andrea

AU - Pallini, Roberto

PY - 2008/3/15

Y1 - 2008/3/15

N2 - Tumor angiogenesis is a complex process that involves a series of interactions between tumor cells and endothelial cells (ECs). In vitro, glioblastoma multiforme (GBM) cells are known to induce an increase in proliferation, migration and tube formation by the ECs. We have previously shown that in human GBM specimens the proliferating ECs of the tumor vasculature express the catalytic component of telomerase, hTERT, and that telomerase can be upregulated in human ECs by exposing these cells to GBM in vitro. Here, we developed a controlled in vivo assay of tumor angiogenesis in which primary human umbilical vascular endothelial cells (HUVECs) were subcutaneously grafted with or without human GBM cells in immunocompromised mice as Matrigel implants. We found that primary HUVECs did not survive in Matrigel implants, and that telomerase upregulation had little effect on HUVEC survival. In the presence of GBM cells, however, the grafted HUVECs not only survived in Matrigel implants but developed tubule structures that integrated with murine microvessels. Telomerase upregulation in HUVECs enhanced such effect. More importantly, inhibition of telomerase in HUVECs completely abolished tubule formation and greatly reduced survival of these cells in the tumor xenografts. Our data demonstrate that telomerase upregulation by the ECs is a key requisite for GBM tumor angiogenesis.

AB - Tumor angiogenesis is a complex process that involves a series of interactions between tumor cells and endothelial cells (ECs). In vitro, glioblastoma multiforme (GBM) cells are known to induce an increase in proliferation, migration and tube formation by the ECs. We have previously shown that in human GBM specimens the proliferating ECs of the tumor vasculature express the catalytic component of telomerase, hTERT, and that telomerase can be upregulated in human ECs by exposing these cells to GBM in vitro. Here, we developed a controlled in vivo assay of tumor angiogenesis in which primary human umbilical vascular endothelial cells (HUVECs) were subcutaneously grafted with or without human GBM cells in immunocompromised mice as Matrigel implants. We found that primary HUVECs did not survive in Matrigel implants, and that telomerase upregulation had little effect on HUVEC survival. In the presence of GBM cells, however, the grafted HUVECs not only survived in Matrigel implants but developed tubule structures that integrated with murine microvessels. Telomerase upregulation in HUVECs enhanced such effect. More importantly, inhibition of telomerase in HUVECs completely abolished tubule formation and greatly reduced survival of these cells in the tumor xenografts. Our data demonstrate that telomerase upregulation by the ECs is a key requisite for GBM tumor angiogenesis.

KW - Glioblastoma multiforme

KW - HUVEC

KW - Telomerase

KW - Tumor xenograft

UR - http://www.scopus.com/inward/record.url?scp=39649094505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39649094505&partnerID=8YFLogxK

U2 - 10.1002/ijc.23193

DO - 10.1002/ijc.23193

M3 - Article

C2 - 18027853

AN - SCOPUS:39649094505

VL - 122

SP - 1236

EP - 1242

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -